Product Description
| Cat Number | PP-300 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | PD-1 - PD-L1 interaction blocker |
| Modification | C terminal amide, amide bridge between Lys-8 and Phe-7 in branch chain |
| Purity | >95% by hplc |
| Biomarker Target | Protein-protein interactions |
| Sequence Three Letter Code | H-Ser-Asn-Thr-Ser-Glu-Ser-Phe-Lys(H-Ser-Asn-Thr-Ser-Glu-Ser-Phe)-Phe-Arg-Val-Thr-Gln-Leu-Ala-Pro-Lys-Ala-Gln-Ile-Lys-Glu-NH2 |
| Molecular Formula | C142H226N40O48 |
| Sl Sequence | SNTSESF-K(SNTSESF)-FRVTQLAPKAQIKE-NH2 |
| Solubility | Soluble in water |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Sasikumar et al (2019 A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy. Mol Cancer Ther. 18(6) 1081 PMID: 31015307 Related areasAll peptides >All protein-protein interaction modulators >All cancer research areas > |
| Note | The product is for research use only |
Share Item: